• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges in the Prevention and Management of Diabetic Kidney Diseases.

作者信息

Sonmez Alper

机构信息

Department of Endocrinology and Metabolism, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

出版信息

Front Clin Diabetes Healthc. 2021 Aug 23;2:728320. doi: 10.3389/fcdhc.2021.728320. eCollection 2021.

DOI:10.3389/fcdhc.2021.728320
PMID:36994322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10012163/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/10012163/7802cd932b2c/fcdhc-02-728320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/10012163/7802cd932b2c/fcdhc-02-728320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/10012163/7802cd932b2c/fcdhc-02-728320-g001.jpg

相似文献

1
Challenges in the Prevention and Management of Diabetic Kidney Diseases.糖尿病肾病预防与管理中的挑战
Front Clin Diabetes Healthc. 2021 Aug 23;2:728320. doi: 10.3389/fcdhc.2021.728320. eCollection 2021.
2
Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.蛋白尿 2 型糖尿病和肾病患者发生终末期肾病与心血管死亡率的相对发生率：来自 DIAMETRIC（糖尿病肾脏并发症防治研究联盟）数据库的结果。
Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.
3
Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.终末期肾病患者 2 型糖尿病：对心血管疾病相关死亡率风险的影响。
Med J Aust. 2018 Nov 19;209(10):440-446. doi: 10.5694/mja18.00195. Epub 2018 Oct 22.
4
Effect of Clinical Inertia on Diabetes Complications among Individuals with Type 2 Diabetes: A Retrospective Cohort Study.临床惰性对 2 型糖尿病患者糖尿病并发症的影响：一项回顾性队列研究。
Medicina (Kaunas). 2021 Dec 31;58(1):63. doi: 10.3390/medicina58010063.
5
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).血清碳酸氢盐与糖尿病肾病患者的肾脏疾病进展和心血管结局：RENAAL（氯沙坦干预降低非胰岛素依赖型糖尿病肾病进展）研究和 IDNT（厄贝沙坦糖尿病肾病试验）的事后分析
Am J Kidney Dis. 2015 Sep;66(3):450-8. doi: 10.1053/j.ajkd.2015.03.032. Epub 2015 May 16.
6
Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.2 型糖尿病肾病患者的血压变异性与肾脏和心血管结局：来自 RENAAL 研究和厄贝沙坦糖尿病肾病试验的事后分析。
Am J Kidney Dis. 2014 Nov;64(5):714-22. doi: 10.1053/j.ajkd.2014.06.008. Epub 2014 Jul 24.
7
Diabetic Nephropathy - possibilities of early laboratory diagnostics and course prediction (review of literature).糖尿病肾病——早期实验室诊断和病程预测的可能性（文献综述）。
Klin Lab Diagn. 2021 Oct 18;66(10):593-602. doi: 10.51620/0869-2084-2021-66-10-593-602.
8
SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.全基因组关联研究热点染色体 9p21 上的 SNP 可导致 1 型糖尿病患者发生糖尿病肾病的易感性。
Diabetologia. 2012 Sep;55(9):2386-93. doi: 10.1007/s00125-012-2587-0. Epub 2012 May 29.
9
Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.通过抗高血压治疗预防和减缓糖尿病肾病的进展。
J Diabetes Complications. 1997 Mar-Apr;11(2):112-22. doi: 10.1016/s1056-8727(96)00105-5.
10
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.芬兰1型（胰岛素依赖型）糖尿病患者伴或不伴糖尿病肾病时心血管疾病的发病率。
Diabetologia. 1998 Jul;41(7):784-90. doi: 10.1007/s001250050988.

引用本文的文献

1
Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis.黄芪联合肾素-血管紧张素-醛固酮系统抑制剂治疗 III 期糖尿病肾病的疗效：系统评价和荟萃分析。
Ren Fail. 2024 Dec;46(2):2359033. doi: 10.1080/0886022X.2024.2359033. Epub 2024 Jun 5.

本文引用的文献

1
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.糖尿病患者的肾脏疾病：从病理生理学到药理学方面，重点关注治疗惰性。
Int J Mol Sci. 2021 May 1;22(9):4824. doi: 10.3390/ijms22094824.
2
A multidimensional framework for rating health system performance and sustainability: A nine plus one ranking system.多维框架评估卫生系统绩效和可持续性：九加一排名系统。
J Glob Health. 2021 May 8;11:04025. doi: 10.7189/jogh.11.04025.
3
10. Cardiovascular Disease and Risk Management: .
10. 心血管疾病与风险管理： 。
Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150. doi: 10.2337/dc21-S010.
4
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).土耳其 2 型糖尿病患者他汀类药物的使用和 LDL-胆固醇达标情况——一项全国性横断面研究（TEMD 血脂异常研究）。
Lipids Health Dis. 2020 Nov 11;19(1):237. doi: 10.1186/s12944-020-01408-2.
5
Prevalence of chronic kidney disease in an admixed population of patients with type 1 diabetes. A multicenter study in Brazil.1 型糖尿病患者混合人群中慢性肾脏病的患病率。巴西的一项多中心研究。
Diabetes Res Clin Pract. 2020 Dec;170:108490. doi: 10.1016/j.diabres.2020.108490. Epub 2020 Oct 1.
6
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2020慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019.
7
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk.2型糖尿病中的慢性肾脏病：对血糖控制、心血管及肾脏风险管理的意义
Diabetes Obes Metab. 2020 Apr;22 Suppl 1:32-45. doi: 10.1111/dom.13942.
8
Cardiorenal risk reduction guidance in diabetes: can we reach consensus?糖尿病中心肾风险降低指南：我们能达成共识吗？
Lancet Diabetes Endocrinol. 2020 May;8(5):357-360. doi: 10.1016/S2213-8587(20)30062-0. Epub 2020 Mar 11.
9
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.糖尿病中抗糖尿病和抗高血压药物过度治疗与去强化治疗的横断面研究：TEMD过度治疗研究
Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22.
10
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.